Sector consensus Middle East Pharmaceutical Industries Company
Stocks
4016
SA160G51UO10
Pharmaceuticals
|
Delayed
Saudi Arabian S.E.
04:45:46 2026-10-08 EDT
|
5-day change | 1st Jan Change | ||
| 63.25 SAR | -1.40% |
|
+0.16% | -0.46% |
| 10-07 | Avalon Pharma, Aurisco to Cooperate on Oligonucleotide Manufacturing in Saudi Arabia | MT |
| 09-17 | Avalon Pharma Renews SAR104 Million Bank Facility Deal with Banque Saudi Fransi | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | - | - | - | 146.4 | +128.22% | 1 | |||
| 1,329.21 | +11.82% | 29 | ||||||
| 279.64 | +8.2% | 22 | ||||||
| 280.79 | +3.47% | 28 | ||||||
| 156.28 | +9.45% | 25 | ||||||
| 375.66 | +4.35% | 19 | ||||||
| 150.73 | +4.69% | 22 | ||||||
| 209.58 | +30.29% | 23 | ||||||
| 391.46 | -5.23% | 29 | ||||||
| 159.27 | +8.46% | 26 | ||||||
| 305.82 | +20.45% | 23 | ||||||
| 29.03 | +3.67% | 26 | ||||||
| 571.39 | +13% | 28 | ||||||
| 66.17 | +10.83% | 24 | ||||||
| 980.67 | +7.73% | 12 | ||||||
| 94.06 | +30.98% | 24 | ||||||
| 21.73 | +21.36% | 21 | ||||||
| 121 | -38.42% | 18 | ||||||
| 856.23 | +15.38% | 26 | ||||||
| 154.21 | +10.04% | 14 | ||||||
| Average | 333.97 | +14.94% | 22 | ||||||
| Weighted average by Cap. | 501.2 | +9.23% | 25 |
Select your edition
All financial news and data tailored to specific country editions
